Feilong Qi
Feilong Qi publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Inflammatory Biomarkers in Disease Prognosis and Extracellular vesicles in disease.
- World rank
- #2,303,086 of 7,710,434 ranked researchers
- Rank in China
- #358,319 of 978,568
- Works
- 15
- Citations
- 724
- Citations per work
- 48.3
What does Feilong Qi research?
Feilong Qi's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else535.6%
- Health Sciences533.3%
- Medicine533.3%
- Life Sciences426.7%
- Physical Sciences14.4%
- Materials Science14.4%
- 1Oncology22% of their works
- 2Molecular Biology18% of their works
- 3Immunology9% of their works
- 4Hepatology7% of their works
- 5Biomaterials4% of their works
- 6Internal Medicine4% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Extracellular vesicles in disease
- Supramolecular Self-Assembly in Materials
- Platelet Disorders and Treatments
- Hepatocellular Carcinoma Treatment and Prognosis
- Venous Thromboembolism Diagnosis and Management
- Peptidase Inhibition and Analysis
Which keywords describe Feilong Qi's research?
The keywords of their largest research topics: Tumor Microenvironment, Inflammation, Platelets, Diagnosis, Immune Checkpoint Blockade, Immunity, Neutrophil-to-Lymphocyte Ratio and PD-1 and PD-L1.
- Venous Thromboembolism
- Self-Assembly
- Immunosuppression
- Hepatocellular Carcinoma
- Extracellular Vesicles
- Antithrombotic Therapy
- PD-1 and PD-L1
- Immunity
- Diagnosis
- Inflammation
- Tumor Microenvironment
- Platelets
- Immune Checkpoint Blockade
- Neutrophil-to-Lymphocyte Ratio
- Treatment
- Exosomes
- Fibroblast Activation Protein
- Immune Thrombocytopenic Purpura
- Liver Cancer
- Supramolecular
- von Willebrand Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Tumor Microenvironment103 topics
- Inflammation62 topics
- Platelets62 topics
- Diagnosis42 topics
- Immune Checkpoint Blockade41 topic
- Immunity41 topic
- Neutrophil-to-Lymphocyte Ratio41 topic
- PD-1 and PD-L141 topic
- Treatment42 topics
- Antithrombotic Therapy21 topic
- Exosomes21 topic
- Extracellular Vesicles21 topic
- Fibroblast Activation Protein21 topic
- Hepatocellular Carcinoma21 topic
- Immune Thrombocytopenic Purpura21 topic
- Immunosuppression21 topic
- Liver Cancer21 topic
- Self-Assembly21 topic
- Supramolecular21 topic
- Venous Thromboembolism21 topic
- von Willebrand Disease21 topic
Where does Feilong Qi work?
Feilong Qi's main affiliation in the publication record is National Center for Nanoscience and Technology, China.
How many publications and citations does Feilong Qi have?
OpenAlex counts 15 works and 724 citations for Feilong Qi, an h-index of 12, ranking #2,303,086 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Feilong Qi. Posts are plain text and can be reported.